期刊文献+

肝细胞肝癌NTS的表达与炎症微环境形成和肿瘤上皮间质转化及预后的相关性研究 被引量:8

Expression of NTS in hepatocellular carcinoma(HCC)is associated with the formation of inflammatory microenvironment,more epithelial mesenchymal transition in cancer,and worse prognosis
下载PDF
导出
摘要 目的:利用免疫组织化学染色法(IHC)检测肝细胞肝癌(HCC)中神经降压素(NTS)的表达,并探讨HCC中NTS/IL-8通路的激活与炎性微环境形成和肿瘤上皮间质转化(EMT)及临床预后的关系。方法:收集本院2007年11月至2009年7月期间进行部分肝切除术后确诊为肝细胞癌(HCC)、随访资料完整的肝癌患者64例。采用IHC法检测肝癌及相应癌旁正常组织中NTS,多种炎症因子和EMT相关蛋白的表达情况,包括IL-8、VEGF、MMP-9、CD68、E-cadherin,β-Catenin和Vimentin的表达水平,并比较不同NTS表达对HCC患者总生存时间(OS)的影响。结果:NTS在HCC中表达率为17.19%(11/64),NTS阳性HCC标本中IL-8阳性率较NTS阴性标本明显增加(90.91%vs.41.17%),二者表达呈正相关(R2=0.298,P=0.006)。NTS和IL-8双阳性(NTS+IL-8+)HCC标本中,VEGF和MMP-9表达显著增加。同时,NTS+IL-8+HCC细胞EMT特征明显,表现为E-Cadherin表达降低和Vi mentin表达升高。在肿瘤中NTS和IL-8共表达与患者的临床疗效呈正相关,术后NTS+IL-8+HCC患者的死亡率比非NTS和IL-8共表达的患者高2.5倍(P=0.022)。NTS+IL-8+HCC患者的OS显著缩短[(24.65±4.45)个月vs.(75.79±16.32)个月,P=0.013)],而死亡风险明显升高,其预期危险比(HR)为3.457。结论:在部分HCC中存在NTS/IL-8炎症通路的异常活化,NTS的高表达与炎症微环境形成和肿瘤EMT与肝癌患者预后较差密切相关。 bjective:This work aims determine the expression of the neurotensin (NTS) gene in hepatocellular carcinoma (HCC) subgrouping using immunohistochemical staining (IHC) as well as to evaluate the correlation between the activation of NTS/IL-8 pathway in HCC and inflammatory response in microenvironment and epithelial mesenchymal transition (EMT) in cancer and in the prognosis of patients. Methods:Tumor tissues and corresponding adjacent normal tissue were collected from 64 cases of HCC patients. The expression levels of NTS protein and multiple inflammation and EMT-related proteins, including IL-8, VEGF, MMP9, CD68, E-Cadherin,β-Catenin, and Vimentin, were examined in 64 cases of paraffin-embedded HCC tissues using the immunohistochemistry (IHC) staining method. The clinical outcome and overall survival (OS) among 64 cases of HCC patients were compared. Results:We found that the frequency of NTS-expressing tissues among all HCC samples was 17.19%(11/64). Significantly increased IL-8 protein was confirmed in 90.91%of NTS+HCC samples and was positively correlated with the levels of NTS protein in cancer tissues (P=0.036), which implied the dysfunctional activation of NTS/IL-8 pathway in HCC. The levels of VEGF and MMP9 were significantly correlated with the co-expression of NTS and IL-8 in HCC. Evident features of EMT, including decreased membrane expression of E-Cadherin and increased accumulation of cytoplasmicβ-Catemin and Vimentin, were found in NTS+IL-8+samples. The co-expression of NTS and IL-8 in cancer was significantly correlated with the clinical outcomes of patients, as the mortality rate of NTS+IL-8+HCC patients is 2.5-fold higher than that of others after surgery (P=0.022).Accordingly, the OS of NTS+IL-8+HCC patients significantly decreased (24.65±4.45 m vs. 75.79±16.32 m, P=0.013), and these patients are at a higher risk of death at an expected hazard ratio (HR) of 3.457. Conclusion:The NTS/IL-8 pathway is dysfunctionally activated in a subgroup of HCC samples. Highly expressed NTS is associated with increased inflammatory response in microenvironment, enhanced EMT in cancer, and worse prognosis in HCC patients.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2013年第19期1150-1154,共5页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金项目(编号:81272360)资助~~
关键词 HCC NTS 炎症微环境 EMT 预后 HCC, NTS, inflammatory microenvironment, EMT, prognosis
  • 相关文献

参考文献16

  • 1Parkin DM, Bray F, FerlayJ, et al. Global cancer statistics, 2002[J]. CA CancerJ Clin, 2005, 55 (2) :74-108.
  • 2Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study[J]. Lancet Oncol, 2012, 13(8):790-801.
  • 3Morrison WB. Inflammation and cancer: a comparative view[J], J Vet Intern Med, 2012, 26(1):18-31.
  • 4Law IK, MurphyJE, Bakirtzi K, et al. Neurotensin-induced proin- flammatory signaling in human colonocytes is regulated by beta-ar- restins and endothelin-converting enzyme-i--dependent endocyto- sis and resensitization of neurotensin receptor 1[J]. J Biol Chem, 2012, 287(18):15066-15075.
  • 5Wang X, Wang O- Ives KL, et al. Curcumin inhibits neuroten- sin-mediated interleukin-8 production and migration of HCTll6 human colon cancer ceils[J]. Clin Cancer Res, 2006, 12(18):5346-5355.
  • 6Can'away R, Leeman SE. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami[J].J Biol Chem, 1973, 248(19): 6854-6861.
  • 7Zhao D, Pothoulakis C. Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation[J]. Peptides, 2006, 27(10): 2434-2444.
  • 8Shimizu S, TsukadaJ, Sugimoto T, et al. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway[J]. IntJ Cancer, 2008, 123(8):1816-1823.
  • 9Valcourt U, Kowanetz M, Niimi H, et al. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal ceU transition[J]. Mol Biol Cell, 2005, 16(4): 1987-2002.
  • 10ReubiJC, Waser B, SchaerJC, et al. Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas[J]. Int J Can- cer, 1999, 82(2):213-218.

二级参考文献20

  • 1Hui-Chuan Sun,Zhao-You Tang,Xiao-Ming Li,Yan-Nan Zhou,Bao-Rong Sun,Zeng-Chen Ma.Microvessel density of hepatocellular carcinoma: its relationship with prognosis[J]. Journal of Cancer Research and Clinical Oncology . 1999 (7)
  • 2Poon D,Anderson BO,Chen LT,Tanaka K,Lau WY,Van Cutsem E,Singh H,Chow WC,Ooi LL,Chow P,Khin MW,Koo WH.Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. The Lancet Oncology . 2009
  • 3Hidai C,Zupancic T,Penta K,Mikhail A,Kawana M,Quer- termous EE,Aoka Y,Fukagawa M,Matsui Y,Platika D,Au-erbach R,Hogan BL,Snodgrass R,Quertermous T.Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphav- beta3 integrin receptor. Genes and Development . 1998
  • 4Quezada A,Larson J,French M,Ponce R,Perrard J,Durland R,Coleman M.Biodistribution and safety studies of hDel-1 plasmid-based gene therapy in mouse and rabbit models. Journal of Pharmacokinetics and Pharmacodynamics . 2004
  • 5Rajagopalan S,Olin JW,Young S,Erikson M,Grossman PM,Mendelsohn FO,Regensteiner JG,Hiatt WR,Annex BH.Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1),a phase II multicenter,double-blind,placebo- controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease. Human Gene Therapy . 2004
  • 6Aoka Y,Johnson FL,Penta K,Hirata Ki K,Hidai C,Schatzman R,Varner JA,Quertermous T.The embryonic an- giogenic factor Del1 accelerates tumor growth by enhancing vascular formation. Microvascular Research . 2002
  • 7Zou X,Qiao H,Jiang X,Dong X,Jiang H,Sun X.Downregu- lation of developmentally regulated endothelial cell locus-1 inhibits the growth of colon cancer. Journal of Biomedical Science . 2008
  • 8Luo JH,Ren B,Keryanov S,Tseng GC,Rao UN,Monga SP,Strom S,Demetris AJ,Nalesnik M,Yu YP,Ranganathan S,Michalopoulos GK.Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology . 2006
  • 9Zhong,J,Eliceiri,B,Stupack,D,Penta,K,Sakamoto,G,Quertermous,T,Coleman,M,Boudreau,N,Varner,JA.Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1. The Journal of Clinical Investigation . 2003
  • 10Park DM,Bray F,Ferlay J,et al.Global cancer statistics,2002. CA A Cancer Journal for Clinicians . 2005

共引文献6

同被引文献101

  • 1应倩,汪媛.肝癌流行现况和趋势分析[J].中国肿瘤,2020,0(3):185-191. 被引量:103
  • 2Melchiorre Cervello,Daniela Foderà,Ada Maria Florena,Maurizio Soresi,Claudio Tripodo,Natale D'Alessandro,Giuseppe Montalto.Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: Possible role in tumor promotion and angiogenesis[J].World Journal of Gastroenterology,2005,11(30):4638-4643. 被引量:21
  • 3Hua Hao,Miao Liu,Ping Wu,Lei Cai,Ke Tang,Pan Yi,Yongsheng Li,Ying Chen,Duyun Ye.Lipoxin A 4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment[J].Cancer Letters.2011(1)
  • 4Fabienne Massa,Aurélie Tormo,Sophie Béraud-Dufour,Thierry Coppola,Jean Mazella.Neurotensin-induced Erk1/2 phosphorylation and growth of human colonic cancer cells are independent from growth factors receptors activation[J].Biochemical and Biophysical Research Communications.2011(1)
  • 5Deuk Chae Na,Jae Eun Lee,Jeong Eun Yoo,Bong-Kyeong Oh,Gi Hong Choi,Young Nyun Park.Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study[J].Experimental and Molecular Pathology.2010(1)
  • 6Reya T, Morrison SJ, Clarke MF, et al. Stem cells, eaneer, and cancer stem ceLLs[ J ]. Nature ,2001,414 (6859) : 105-111.
  • 7Yang J, Liao D, Chen C, et al. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/ Stat3/Sox-2 signaling pathway [ J ]. Stem Cells, 2013,31 ( 2 ) : 248- 258.
  • 8Jinushi M, Chiba S, Yoshiyama H, et al. Tumor-associated maempha- ges regulate tumorigenicity and antieaneer drug responses of cancer stem/initiating ceils [ J ]. Proe Natl Aead Sei U S A,2011,108 (30) : 12425-12430.
  • 9Lee EK, Kim DG, Kim JS, et al. Cell-cycle regulator Cksl promotes hepatocellular carcinoma by supporting NF-KB-dependent expression of interleukin-8 [ J]. Cancer Res ,2011,71 ( 21 ) :6827-6835.
  • 10Pettini F, Savino M, Corsalini M, et al. Cytogenetic genotoxicinvestigation in peripheral blood lymphocytes of subjects withdental composite restorative filling materials [ J ]. J Biol RegulHomeost Agents, 2015 ,29( 1) :229-33.

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部